Blood-pressure drugs and cancer: much ado about nothing?-Reference-Cited by-同舟云学术

Blood-pressure drugs and cancer: much ado about nothing?

Published:2011-01 Issue:1 Volume:12 Page:6-8
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lindholm Lars H,Carlberg Bo

Publisher

Elsevier BV

Subject

Oncology

Reference7 articles.

1. High blood pressure: a risk for cancer mortality;Dyer;Lancet,1975

2. Relation between drug treatment and cancer in hypertensives in Swedish Trial in Old Patients with Hypertension 2: a 5-year prospective randomised controlled trial;Lindholm;Lancet,2001

3. Do inhibitors of angiotensin-1-converting enzyme protect against risk of cancer?;Lever;Lancet,1998

4. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials;Sipahi;Lancet Oncol,2010

5. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials;Bangalore;Lancet Oncol,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between 19 medication use and risk of common cancers: A cross-sectional and Mendelian randomisation study;Journal of Global Health;2024-03-15

2. The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors;Journal of Cardiovascular Development and Disease;2023-10-15

3. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies;Therapeutic Advances in Drug Safety;2022-01

4. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cancer Risk: An Updated Meta-Analysis of Observational Studies;SSRN Electronic Journal;2022

5. Angiotensin II-induced hypertension increases the mutant frequency in rat kidney;Archives of Toxicology;2019-05-16